Related Experiment Video
Updated: Mar 24, 2026

Generation of Brown Fat-Specific Knockout Mice Using a Combined Cre-LoxP, CRISPR-Cas9, and Adeno-Associated Virus Single-Guide RNA System
Published on: March 24, 2023
Cdkn1c Boosts the Development of Brown Adipose Tissue in a Murine Model of Silver Russell Syndrome
Matthew Van De Pette1, Simon J Tunster1, Grainne I McNamara1
1School of Biosciences, Cardiff University, Cardiff, United Kingdom.
Abstract:
The accurate diagnosis and clinical management of the growth restriction disorder Silver Russell Syndrome (SRS) has confounded researchers and clinicians for many years due to the myriad of genetic and epigenetic alterations reported in these patients and the lack of suitable animal models to test the contribution of specific gene alterations. Some genetic alterations suggest a role for increased dosage of the imprinted CYCLIN DEPENDENT KINASE INHIBITOR 1C (CDKN1C) gene, often mutated in IMAGe Syndrome and Beckwith-Wiedemann Syndrome (BWS). Cdkn1c encodes a potent negative regulator of fetal growth that also regulates placental development, consistent with a proposed role for CDKN1C in these complex childhood growth disorders. Here, we report that a mouse modelling the rare microduplications present in some SRS patients exhibited phenotypes including low birth weight with relative head sparing, neonatal hypoglycemia, absence of catch-up growth and significantly reduced adiposity as adults, all defining features of SRS. Further investigation revealed the presence of substantially more brown adipose tissue in very young mice, of both the classical or canonical type exemplified by interscapular-type brown fat depot in mice (iBAT) and a second type of non-classic BAT that develops postnatally within white adipose tissue (WAT), genetically attributable to a double dose of Cdkn1c in vivo and ex-vivo. Conversely, loss-of-function of Cdkn1c resulted in the complete developmental failure of the brown adipocyte lineage with a loss of markers of both brown adipose fate and function. We further show that Cdkn1c is required for post-transcriptional accumulation of the brown fat determinant PR domain containing 16 (PRDM16) and that CDKN1C and PRDM16 co-localise to the nucleus of rare label-retaining cell within iBAT. This study reveals a key requirement for Cdkn1c in the early development of the brown adipose lineages. Importantly, active BAT consumes high amounts of energy to generate body heat, providing a valid explanation for the persistence of thinness in our model and supporting a major role for elevated CDKN1C in SRS.
Insights
Altered CYCLIN DEPENDENT KINASE INHIBITOR 1C (CDKN1C) gene dosage impacts growth and adipose tissue development. This study reveals CDKN1C
Area of Science:
- Genetics
- Developmental Biology
- Endocrinology
Background:
- Silver Russell Syndrome (SRS) diagnosis and management are challenging due to complex genetic and epigenetic factors.
- The imprinted CYCLIN DEPENDENT KINASE INHIBITOR 1C (CDKN1C) gene, a growth regulator, is implicated in SRS, IMAGe Syndrome, and Beckwith-Wiedemann Syndrome (BWS).
- Previous research suggests increased CDKN1C dosage may contribute to growth restriction disorders.
Purpose of the Study:
- To investigate the role of CDKN1C gene dosage in Silver Russell Syndrome (SRS) pathogenesis.
- To explore the impact of altered CDKN1C levels on fetal growth, placental development, and adipose tissue formation.
- To elucidate the molecular mechanisms by which CDKN1C regulates brown adipose tissue development.
Main Methods:
- Generated a mouse model with microduplications of the imprinted CDKN1C gene, mimicking rare SRS cases.
- Analyzed phenotypic features including birth weight, head sparing, hypoglycemia, growth, and adiposity.
- Investigated brown adipose tissue (BAT) development and function, including PR domain containing 16 (PRDM16) regulation.
Main Results:
- The SRS mouse model exhibited low birth weight, neonatal hypoglycemia, lack of catch-up growth, and reduced adult adiposity.
- Increased CDKN1C dosage led to enhanced classical (iBAT) and non-classical brown adipose tissue development.
- Loss of CDKN1C function resulted in complete developmental failure of brown adipocytes and loss of PRDM16 expression.
Conclusions:
- Elevated CDKN1C levels are crucial for the early development of brown adipose lineages.
- The study provides a mechanistic explanation for thinness in SRS models, linking it to increased CDKN1C and active BAT.
- This research highlights a significant role for CDKN1C in regulating energy expenditure through brown adipose tissue development in growth disorders.
More Related Videos
09:52Investigation of Beige Fat Biology and Metabolism Using the CRISPR SunTag-p65-HSF1 Activation System
Published on: January 6, 2023
04:46Differentiation and Imaging of Brown Adipocytes from the Stromal Vascular Fraction of Interscapular Adipose Tissue from Newborn Mice
Published on: February 3, 2023